Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Kalb, Suzanne R ^a   Garcia Rodriguez, Consuelo ^b   Lou, Jianlong ^b   Baudys, Jakub ^c   Smith, Theresa J ^d   Marks, James D ^b   Smith, Leonard A ^d   Pirkle, James L ^a   Barr, John R ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; BOTULINUM TOXIN F; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E17.1; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; FEMALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; SEQUENCE ALIGNMENT; SEROTYPE; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CROSS REACTION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; STATISTICAL PARAMETERS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CROSS REACTIONS; ENDOPEPTIDASES; FEMALE; HUMANS; LIMIT OF DETECTION; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA;

EID: 77957876488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012237     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention (1998) Botulism in the United States: 1899-1996. Handbook for Epidemiologists, Clinicians and Laboratory Workers. Atlanta: Centers for Disease Control and Prevention Press. 43 p.
2. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80(2): 717-766.
3. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, et al. (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285(8): 1059-1070.
4. Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, et al. (2005) Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis 11(10): 1578-1583.
5. Boyer AE, Moura H, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. (2005) From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal Chem 7: 3916-3924.
6. Kalb SR, Moura H, Boyer AE, McWilliams LG, Pirkle JL, et al. (2006) The Use of Endopep-MS for the detection of botulinum neurotoxins A, B, E, and F in serum and stool samples. Anal Biochem 351(1): 84-92.
7. Kalb SR, Goodnough MC, Malizio CJ, Pirkle JL, Barr JR (2005) Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal Chem 77(19): 6140-6146.
8. Gaunt PS, Kalb SR, Barr JR (2007) Detection of Botulinum Type E Toxin in channel catfish with visceral toxicosis syndrome using catfish bioassay and endopep mass spectrometry. J Vet Diagn Invest 19(4): 349-354.
9. Kalb SR, Smith TJ, Moura H, Hill K, Lou J, et al. (2008) The Use of Endopep- MS to detect multiple subtypes of botulinum neurotoxins A, B, E, and F. International Journal of Mass Spectrometry 278: 101-108.
10. Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, et al. (2009) Extraction and Inhibition of Enzymatic Activity of BoNT/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies. PLoS One 4(4): e5355.
11. Kautter DA, Solomon HM (1977) Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods. J Assoc Anal Chem 60(3): 541-545.
12. Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, et al. (2002) Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci USA 99(17): 11346-11350.
13. Amersdorfer P, Wong C, Smith T, Chen S, Desphande S, et al. (2002) Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Vaccine 20: 1640-1648.
14. Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, et al. (2010) Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Engineering, Design & Selection. pp 1-9. Doi:10.1093/protein/gzq001.
15. Fischer A, Garcia-Rodriguez C, Geren I, Lou J, Marks JD, et al. (2008) Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy. J Biol Chem 283: 3997-4003.
16. Mah DC, Hu WG, Pon JK, Masri SA, Fulton RE, et al. (2003) Recombinant anti-botulinum neurotoxin A single-chain variable fragment antibody generated using a phage display system. Hybrid Hybridomics 22(5): 277-285.
17. Garcia-Rodriguez D, Geren IN, Lou J, Conrad F, Forsyth C, et al. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin, submitted to PEDS.
18. Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, et al. (2007) Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol 25: 107-116.
19. Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, et al. (2007) Fine and domain-level epitope mapping of botulinum neurotoxin type a neutralizing antibodies by yeast surface display. J Mol Biol 365: 196-210.
20. Carter AT, Paul CJ, Mason DR, Twine SM, Alston MJ, et al. (2009) Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 19(10): 115.
21. Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S (2009) Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J Clin Microbiol 47(9): 2720-2728.
22. Wang X, Maegawa T, Karasawa T, Kozaki S, Tsukamoto K, et al. (2000) Genetic analysis of type E botulinum toxin-producint Clostridium butyricum strains. Appl Environ Microbiol 66(11): 4992-7.
23. Chen Y, Korkeala H, Aarnikunnas J, Lindstrom M (2007) Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J Bacteriol 189(23): 8654-50.
24. Raphael BH, Choudoir MJ, Luquez C, Fernandez R, Maslanka SE (2010) Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol, in press.